Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/37159
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | AMGAD, Mohamed | - |
dc.contributor.author | STOVGAARD, Elisabeth Specht | - |
dc.contributor.author | BALSLEV, Eva | - |
dc.contributor.author | THAGAARD, Jeppe | - |
dc.contributor.author | CHEN, Weijie | - |
dc.contributor.author | DUDGEON, Sarah | - |
dc.contributor.author | SHARMA, Ashish | - |
dc.contributor.author | KERNER, Jennifer K. | - |
dc.contributor.author | DENKERT, Carsten | - |
dc.contributor.author | YUAN, Yinyin | - |
dc.contributor.author | ABDULJABBAR, Khalid | - |
dc.contributor.author | WIENERT, Stephan | - |
dc.contributor.author | SAVAS, Peter | - |
dc.contributor.author | VOORWERK, Leonie | - |
dc.contributor.author | BECK, Andrew H. | - |
dc.contributor.author | MADABHUSHI, Anant | - |
dc.contributor.author | HARTMAN, Johan | - |
dc.contributor.author | SEBASTIAN, Manu M. | - |
dc.contributor.author | HORLINGS, Hugo M. | - |
dc.contributor.author | HUDECEK, Jan | - |
dc.contributor.author | CIOMPI, Francesco | - |
dc.contributor.author | MOORE, David A. | - |
dc.contributor.author | SINGH, Rajendra | - |
dc.contributor.author | ROBLIN, Elvire | - |
dc.contributor.author | BALANCIN, Marcelo Luiz | - |
dc.contributor.author | MATHIEU, Marie-Christine | - |
dc.contributor.author | LENNERZ, Jochen K. | - |
dc.contributor.author | KIRTANI, Pawan | - |
dc.contributor.author | CHEN, I-Chun | - |
dc.contributor.author | BRAYBROOKE, Jeremy P. | - |
dc.contributor.author | PRUNERI, Giancarlo | - |
dc.contributor.author | DEMARIA, Sandra | - |
dc.contributor.author | ADAMS, Sylvia | - |
dc.contributor.author | SCHNITT, Stuart J. | - |
dc.contributor.author | LAKHANI, Sunil R. | - |
dc.contributor.author | ROJO, Federico | - |
dc.contributor.author | COMERMA, Laura | - |
dc.contributor.author | BADVE, Sunil S. | - |
dc.contributor.author | KHOJASTEH, Mehrnoush | - |
dc.contributor.author | SYMMANS, W. Fraser | - |
dc.contributor.author | SOTIRIOU, Christos | - |
dc.contributor.author | GONZALEZ-ERICSSON, Paula | - |
dc.contributor.author | POGUE-GEILE, Katherine L. | - |
dc.contributor.author | KIM, Rim S. | - |
dc.contributor.author | RIMM, David L. | - |
dc.contributor.author | VIALE, Giuseppe | - |
dc.contributor.author | HEWITT, Stephen M. | - |
dc.contributor.author | BARTLETT, John M. S. | - |
dc.contributor.author | PENAULT-LLORCA, Frederique | - |
dc.contributor.author | GOEL, Shom | - |
dc.contributor.author | LIEN, Huang-Chun | - |
dc.contributor.author | LOIBL, Sibylle | - |
dc.contributor.author | KOS, Zuzana | - |
dc.contributor.author | LOI, Sherene | - |
dc.contributor.author | HANNA, Matthew G. | - |
dc.contributor.author | MICHIELS, Stefan | - |
dc.contributor.author | KOK, Marleen | - |
dc.contributor.author | NIELSEN, Torsten O. | - |
dc.contributor.author | LAZAR, Alexander J. | - |
dc.contributor.author | BAGO-HORVATH, Zsuzsanna | - |
dc.contributor.author | KOOREMAN, Loes F. S. | - |
dc.contributor.author | LAAK, Jeroen A. W. M. van der | - |
dc.contributor.author | SALTZ, Joel | - |
dc.contributor.author | GALLAS, Brandon D. | - |
dc.contributor.author | KURKURE, Uday | - |
dc.contributor.author | BARNES, Michael | - |
dc.contributor.author | SALGADO, Roberto | - |
dc.contributor.author | COOPER, Lee A. D. | - |
dc.date.accessioned | 2020-08-20T13:27:40Z | - |
dc.date.available | 2020-08-20T13:27:40Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | NPJ BREAST CANCER, v.6, n.1, article ID 16, 13p, 2020 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/37159 | - |
dc.description.abstract | Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer, as well as many other solid tumors. This recognition has come about thanks to standardized visual reporting guidelines, which helped to reduce inter-reader variability. Now, there are ripe opportunities to employ computational methods that extract spatio-morphologic predictive features, enabling computer-aided diagnostics. We detail the benefits of computational TILs assessment, the readiness of TILs scoring for computational assessment, and outline considerations for overcoming key barriers to clinical translation in this arena. Specifically, we discuss: 1. ensuring computational workflows closely capture visual guidelines and standards; 2. challenges and thoughts standards for assessment of algorithms including training, preanalytical, analytical, and clinical validation; 3. perspectives on how to realize the potential of machine learning models and to overcome the perceptual and practical limits of visual scoring. | eng |
dc.description.sponsorship | National Institutes of Health National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA220401, U24CA19436201] | - |
dc.description.sponsorship | Breast Cancer Research Foundation (BCRF) [17-194] | - |
dc.description.sponsorship | NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1UG3CA225021, 1U24CA215109, 1U24CA199374-01, R01CA202752-01A1, R01CA208236-01A1, R01 CA21657901A1, R01 CA220581-01A1, 1U01 CA239055-01, Leidos 14 x 138] | - |
dc.description.sponsorship | National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 C06 RR12463-01] | - |
dc.description.sponsorship | VA Merit Review Award from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [IBX004121A] | - |
dc.description.sponsorship | DOD Prostate Cancer Idea Development Award [W81XWH-15-1-0558] | - |
dc.description.sponsorship | DOD Lung Cancer InvestigatorInitiated Translational Research Award [W81XWH-18-1-0440] | - |
dc.description.sponsorship | DOD Peer Reviewed Cancer Research Program [W81XWH-16-1-0329] | - |
dc.description.sponsorship | Ohio Third Frontier Technology Validation Fund | - |
dc.description.sponsorship | Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering | - |
dc.description.sponsorship | Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University | - |
dc.description.sponsorship | Susan G Komen FoundationSusan G. Komen Breast Cancer Foundation [CCR CCR18547966] | - |
dc.description.sponsorship | Breast Cancer Alliance | - |
dc.description.sponsorship | Canadian Cancer Society | - |
dc.description.sponsorship | DHHS/NCI Cancer Center Support Grant (CCSG)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA16672] | - |
dc.language.iso | eng | - |
dc.publisher | NATURE PUBLISHING GROUP | eng |
dc.relation.ispartof | Npj Breast Cancer | - |
dc.rights | openAccess | eng |
dc.subject.other | breast-cancer | eng |
dc.subject.other | standardized method | eng |
dc.subject.other | digital pathology | eng |
dc.subject.other | quality-control | eng |
dc.subject.other | image-analysis | eng |
dc.subject.other | solid tumors | eng |
dc.subject.other | t-cells | eng |
dc.subject.other | in-situ | eng |
dc.subject.other | tils | eng |
dc.subject.other | classification | eng |
dc.title | Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group | eng |
dc.type | article | eng |
dc.rights.holder | Copyright NATURE PUBLISHING GROUP | eng |
dc.contributor.groupauthor | Int Immuno-Oncology Biomarker | - |
dc.identifier.doi | 10.1038/s41523-020-0154-2 | - |
dc.identifier.pmid | 32411818 | - |
dc.subject.wos | Oncology | eng |
dc.type.category | review | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | AMGAD, Mohamed:Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA | - |
hcfmusp.author.external | STOVGAARD, Elisabeth Specht:Univ Copenhagen, Herlev & Gentofte Hosp, Dept Pathol, Herlev, Denmark | - |
hcfmusp.author.external | BALSLEV, Eva:Univ Copenhagen, Herlev & Gentofte Hosp, Dept Pathol, Herlev, Denmark | - |
hcfmusp.author.external | THAGAARD, Jeppe:Tech Univ Denmark, Dept Appl Math, DTU Compute, Lyngby, Denmark; Visiopharm AS, Horsholm, Denmark | - |
hcfmusp.author.external | CHEN, Weijie:FDA CDRH OSEL, Div Imaging Diagnost & Software Reliabil, Silver Spring, MD USA | - |
hcfmusp.author.external | DUDGEON, Sarah:FDA CDRH OSEL, Div Imaging Diagnost & Software Reliabil, Silver Spring, MD USA | - |
hcfmusp.author.external | SHARMA, Ashish:Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA | - |
hcfmusp.author.external | KERNER, Jennifer K.:PathAI, Cambridge, MA USA | - |
hcfmusp.author.external | DENKERT, Carsten:Philipps Univ Marburg, Univ Klinikum Giessen & Marburg GmbH, Inst Pathol, Standort Marburg, Marburg, Germany; Philipps Univ Marburg, Inst Pathol, Marburg, Germany; German Canc Consortium DKTK, Partner Site Charite, Berlin, Germany | - |
hcfmusp.author.external | YUAN, Yinyin:Inst Canc Res, Ctr Evolut & Canc, London, England; Inst Canc Res, Div Mol Pathol, London, England | - |
hcfmusp.author.external | ABDULJABBAR, Khalid:Inst Canc Res, Ctr Evolut & Canc, London, England; Inst Canc Res, Div Mol Pathol, London, England | - |
hcfmusp.author.external | WIENERT, Stephan:Philipps Univ Marburg, Univ Klinikum Giessen & Marburg GmbH, Inst Pathol, Standort Marburg, Marburg, Germany | - |
hcfmusp.author.external | SAVAS, Peter:Univ Melbourne, Div Res & Canc Med, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia | - |
hcfmusp.author.external | VOORWERK, Leonie:Netherlands Canc Inst, Dept Tumor Biol & Immunol, Amsterdam, Netherlands | - |
hcfmusp.author.external | BECK, Andrew H.:PathAI, Cambridge, MA USA | - |
hcfmusp.author.external | MADABHUSHI, Anant:Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; Louis Stokes Cleveland Vet Adm Med Ctr, Cleveland, OH USA | - |
hcfmusp.author.external | HARTMAN, Johan:Karolinska Inst, Dept Pathol & Oncol, Solna, Sweden; Univ Hosp, Solna, Sweden | - |
hcfmusp.author.external | SEBASTIAN, Manu M.:Univ Texas MD Anderson Canc Ctr, Dept Epigenet, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Houston, TX 77030 USA | - |
hcfmusp.author.external | HORLINGS, Hugo M.:Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands | - |
hcfmusp.author.external | HUDECEK, Jan:Netherlands Canc Inst, Dept Res IT, Amsterdam, Netherlands | - |
hcfmusp.author.external | CIOMPI, Francesco:Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands | - |
hcfmusp.author.external | MOORE, David A.:UCL Canc Inst, Dept Pathol, London, England; Icahn Sch Med Mt Sinai, Dept Pathol & Lab Med, New York, NY 10029 USA | - |
hcfmusp.author.external | SINGH, Rajendra:Icahn Sch Med Mt Sinai, Dept Pathol & Lab Med, New York, NY 10029 USA | - |
hcfmusp.author.external | ROBLIN, Elvire:Univ Paris Sud, Univ Paris Saclay, Villejuif, France | - |
hcfmusp.author.external | MATHIEU, Marie-Christine:Gustave Roussy Canc Campus, Dept Mol Biol & Pathol, Villejuif, France | - |
hcfmusp.author.external | LENNERZ, Jochen K.:Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA | - |
hcfmusp.author.external | KIRTANI, Pawan:Manipal Hosp Dwarka, Dept Histopathol, New Delhi, India | - |
hcfmusp.author.external | CHEN, I-Chun:Natl Taiwan Univ, Ctr Canc, Dept Oncol, Taipei, Taiwan | - |
hcfmusp.author.external | BRAYBROOKE, Jeremy P.:Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; Univ Hosp Bristol NHS Fdn Trust, Dept Med Oncol, Bristol, Avon, England | - |
hcfmusp.author.external | PRUNERI, Giancarlo:Ist Nazl Tumori, Fdn IRCCS, Dept Pathol, Milan, Italy; Univ Milan, Sch Med, Milan, Italy | - |
hcfmusp.author.external | DEMARIA, Sandra:Weill Cornell Med Coll, New York, NY USA | - |
hcfmusp.author.external | ADAMS, Sylvia:NYU Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA | - |
hcfmusp.author.external | SCHNITT, Stuart J.:Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA | - |
hcfmusp.author.external | LAKHANI, Sunil R.:Univ Queensland, Ctr Clin Res & Pathol, Brisbane, Qld, Australia | - |
hcfmusp.author.external | ROJO, Federico:CIBERONC Inst Invest Sanitaria Fdn Jimenez Diaz I, Dept Pathol, Madrid, Spain; GEICAM Spanish Breast Canc Res Grp, Madrid, Spain | - |
hcfmusp.author.external | COMERMA, Laura:CIBERONC Inst Invest Sanitaria Fdn Jimenez Diaz I, Dept Pathol, Madrid, Spain; GEICAM Spanish Breast Canc Res Grp, Madrid, Spain | - |
hcfmusp.author.external | BADVE, Sunil S.:Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA | - |
hcfmusp.author.external | KHOJASTEH, Mehrnoush:Roche Tissue Diagnost, Digital Pathol, Santa Clara, CA USA | - |
hcfmusp.author.external | SYMMANS, W. Fraser:Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA | - |
hcfmusp.author.external | SOTIRIOU, Christos:Univ Libre Bruxelles ULB, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium; Univ Libre Bruxelles, ULB Canc Res Ctr U CRC, Brussels, Belgium | - |
hcfmusp.author.external | GONZALEZ-ERICSSON, Paula:Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Breast Canc Program, Nashville, TN USA | - |
hcfmusp.author.external | POGUE-GEILE, Katherine L.:NRG Oncol NSABP, Pittsburgh, PA USA | - |
hcfmusp.author.external | KIM, Rim S.:NRG Oncol NSABP, Pittsburgh, PA USA | - |
hcfmusp.author.external | RIMM, David L.:Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA | - |
hcfmusp.author.external | VIALE, Giuseppe:European Inst Oncol IRCCS, IEO, Dept Pathol, Milan, Italy; State Univ Milan, Milan, Italy | - |
hcfmusp.author.external | HEWITT, Stephen M.:NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA | - |
hcfmusp.author.external | BARTLETT, John M. S.:Ontario Inst Canc Res, Toronto, ON, Canada; Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland | - |
hcfmusp.author.external | PENAULT-LLORCA, Frederique:Ctr Jean Perrin, Dept Pathol & Mol Pathol, Clermont Ferrand, France; Univ Clermont Auvergne, INSERM, UMR 1240, Clermont Ferrand, France | - |
hcfmusp.author.external | GOEL, Shom:Peter MacCallum Canc Ctr, Victorian Comprehens Canc Ctr Bldg, Melbourne, Vic, Australia | - |
hcfmusp.author.external | LIEN, Huang-Chun:Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan | - |
hcfmusp.author.external | LOIBL, Sibylle:GBG Forsch GmbH, German Breast Grp, Neu Isenburg, Germany | - |
hcfmusp.author.external | KOS, Zuzana:BC Canc, Dept Pathol, Vancouver, BC, Canada | - |
hcfmusp.author.external | LOI, Sherene:Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; Peter MacCallum Canc Ctr, Melbourne, Vic, Australia | - |
hcfmusp.author.external | HANNA, Matthew G.:Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA | - |
hcfmusp.author.external | MICHIELS, Stefan:Univ Paris Saclay, Gustave Roussy, Villejuif, France; Univ Paris Sud, INSERM, Villejuif, France | - |
hcfmusp.author.external | KOK, Marleen:Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands | - |
hcfmusp.author.external | NIELSEN, Torsten O.:Univ British Columbia, Vancouver, BC, Canada | - |
hcfmusp.author.external | LAZAR, Alexander J.:Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA | - |
hcfmusp.author.external | BAGO-HORVATH, Zsuzsanna:Med Univ Vienna, Dept Pathol, Vienna, Austria | - |
hcfmusp.author.external | KOOREMAN, Loes F. S.:Maastricht Univ, GROW Sch Oncol & Dev Biol, Med Ctr, Maastricht, Netherlands; Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands | - |
hcfmusp.author.external | LAAK, Jeroen A. W. M. van der:Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands; Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden | - |
hcfmusp.author.external | SALTZ, Joel:SUNY Stony Brook, Dept Biomed Informat, Stony Brook, NY 11794 USA | - |
hcfmusp.author.external | GALLAS, Brandon D.:FDA CDRH OSEL, Div Imaging Diagnost & Software Reliabil, Silver Spring, MD USA | - |
hcfmusp.author.external | KURKURE, Uday:Roche Tissue Diagnost, Digital Pathol, Santa Clara, CA USA | - |
hcfmusp.author.external | BARNES, Michael:Roche Diagnost Informat Solut, Belmont, CA USA | - |
hcfmusp.author.external | SALGADO, Roberto:Univ Melbourne, Div Res & Canc Med, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; GZA ZNA Ziekenhuizen, Dept Pathol, Antwerp, Belgium | - |
hcfmusp.author.external | COOPER, Lee A. D.:Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA | - |
hcfmusp.description.articlenumber | 16 | - |
hcfmusp.description.issue | 1 | - |
hcfmusp.description.volume | 6 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000544983100002 | - |
hcfmusp.origem.id | 2-s2.0-85083451193 | - |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Abramson RG, 2015, ACAD RADIOL, V22, P25, DOI 10.1016/j.acra.2014.09.001 | eng |
hcfmusp.relation.reference | Acs B, 2017, DIAGN PATHOL, V12, P1, DOI 10.1186/s13000-017-0608-5 | eng |
hcfmusp.relation.reference | Amgad M, 2019, PROC SPIE, V10956, DOI 10.1117/12.2512892 | eng |
hcfmusp.relation.reference | Amgad M, 2019, BIOINFORMATICS, V35, P3461, DOI 10.1093/bioinformatics/btz083 | eng |
hcfmusp.relation.reference | Anderson R, 2010, METHODS MOL BIOL, V659, P83, DOI 10.1007/978-1-60761-789-1_6 | eng |
hcfmusp.relation.reference | Balic M, 2019, BREAST CARE, V14, P103, DOI 10.1159/000499931 | eng |
hcfmusp.relation.reference | Barua S, 2018, LUNG CANCER, V117, P73, DOI 10.1016/j.lungcan.2018.01.022 | eng |
hcfmusp.relation.reference | Basavanhally AN, 2010, IEEE T BIO-MED ENG, V57, P642, DOI 10.1109/TBME.2009.2035305 | eng |
hcfmusp.relation.reference | Beck AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001794 | eng |
hcfmusp.relation.reference | Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564 | eng |
hcfmusp.relation.reference | Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585 | eng |
hcfmusp.relation.reference | Blom S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15798-4 | eng |
hcfmusp.relation.reference | Brambilla E, 2016, J CLIN ONCOL, V34, P1223, DOI 10.1200/JCO.2015.63.0970 | eng |
hcfmusp.relation.reference | Brown JR, 2014, CLIN CANCER RES, V20, P5995, DOI 10.1158/1078-0432.CCR-14-1622 | eng |
hcfmusp.relation.reference | Brunye TT, 2017, J BIOMED INFORM, V66, P171, DOI 10.1016/j.jbi.2017.01.004 | eng |
hcfmusp.relation.reference | Buisseret L, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1257452 | eng |
hcfmusp.relation.reference | Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171 | eng |
hcfmusp.relation.reference | Cantini L, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0038-8 | eng |
hcfmusp.relation.reference | Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05570-1 | eng |
hcfmusp.relation.reference | Cooper LAD, 2018, J PATHOL, V244, P512, DOI 10.1002/path.5028 | eng |
hcfmusp.relation.reference | Corredor G, 2019, CLIN CANCER RES, V25, P1526, DOI 10.1158/1078-0432.CCR-18-2013 | eng |
hcfmusp.relation.reference | Denkert C, 2016, MODERN PATHOL, V29, P1155, DOI 10.1038/modpathol.2016.109 | eng |
hcfmusp.relation.reference | Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370 | eng |
hcfmusp.relation.reference | Dieci MV, 2018, SEMIN CANCER BIOL, V52, P16, DOI 10.1016/j.semcancer.2017.10.003 | eng |
hcfmusp.relation.reference | Dobbin KK, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0179-0 | eng |
hcfmusp.relation.reference | Fauzi MFA, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0235-6 | eng |
hcfmusp.relation.reference | Fda M., 2016, GUIDANCE IND FOOD DR | eng |
hcfmusp.relation.reference | Finotello F, 2018, CANCER IMMUNOL IMMUN, V67, P1031, DOI 10.1007/s00262-018-2150-z | eng |
hcfmusp.relation.reference | Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287 | eng |
hcfmusp.relation.reference | Gavrielides MA, 2011, ARCH PATHOL LAB MED, V135, P233, DOI 10.1043/1543-2165-135.2.233 | eng |
hcfmusp.relation.reference | Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909 | eng |
hcfmusp.relation.reference | Goranzon C, 2013, J Crohns Colitis, V7, pe434, DOI 10.1016/j.crohns.2013.02.007 | eng |
hcfmusp.relation.reference | Guidotti R, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3236009 | eng |
hcfmusp.relation.reference | Gurcan Metin N, 2016, Microsc Microanal, V22, P1004, DOI 10.1017/S1431927616005869 | eng |
hcfmusp.relation.reference | Hamilton PW, 2014, METHODS, V70, P59, DOI 10.1016/j.ymeth.2014.06.015 | eng |
hcfmusp.relation.reference | Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3 | eng |
hcfmusp.relation.reference | Hayes DF, 2018, JAMA ONCOL, V4, P773, DOI 10.1001/jamaoncol.2017.4018 | eng |
hcfmusp.relation.reference | Heindl A, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx137 | eng |
hcfmusp.relation.reference | Hendry S, 2017, ADV ANAT PATHOL, V24, P311, DOI 10.1097/PAP.0000000000000161 | eng |
hcfmusp.relation.reference | Hendry S, 2017, ADV ANAT PATHOL, V24, P235, DOI 10.1097/PAP.0000000000000162 | eng |
hcfmusp.relation.reference | Herrmann Markus D, 2018, J Pathol Inform, V9, P37, DOI 10.4103/jpi.jpi_42_18 | eng |
hcfmusp.relation.reference | Hipp Jason, 2011, J Pathol Inform, V2, P25, DOI 10.4103/2153-3539.82050 | eng |
hcfmusp.relation.reference | Holten-Rossing H, 2015, BREAST CANCER RES TR, V152, P367, DOI 10.1007/s10549-015-3475-3 | eng |
hcfmusp.relation.reference | Hou L., 2017, UNSUPERVISED HISTOPA | eng |
hcfmusp.relation.reference | Janowczyk A, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00157 | eng |
hcfmusp.relation.reference | Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902 | eng |
hcfmusp.relation.reference | Klauschen F, 2018, SEMIN CANCER BIOL, V52, P151, DOI 10.1016/j.semcancer.2018.07.001 | eng |
hcfmusp.relation.reference | Kwolek B, 2019, LECT NOTES COMPUT SC, V11731, P299, DOI 10.1007/978-3-030-30493-5_31 | eng |
hcfmusp.relation.reference | Leo P, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.4.047502 | eng |
hcfmusp.relation.reference | Litjens G, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy065 | eng |
hcfmusp.relation.reference | Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005 | eng |
hcfmusp.relation.reference | Lloyd Mark C, 2010, J Pathol Inform, V1, P29, DOI 10.4103/2153-3539.74186 | eng |
hcfmusp.relation.reference | Loi S, 2019, J CLIN ONCOL, V37, P559, DOI 10.1200/JCO.18.01010 | eng |
hcfmusp.relation.reference | Longuespee R, 2014, OMICS, V18, P539, DOI 10.1089/omi.2014.0033 | eng |
hcfmusp.relation.reference | Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008 | eng |
hcfmusp.relation.reference | Masucci GV, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0178-1 | eng |
hcfmusp.relation.reference | Meier A, 2018, ANN ONCOL, V29, P23 | eng |
hcfmusp.relation.reference | Mobadersany P, 2018, P NATL ACAD SCI USA, V115, pE2970, DOI 10.1073/pnas.1717139115 | eng |
hcfmusp.relation.reference | Mukherjee A, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0056-8 | eng |
hcfmusp.relation.reference | Nalisnik M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15092-3 | eng |
hcfmusp.relation.reference | Natrajan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001961 | eng |
hcfmusp.relation.reference | O'Connor JPB, 2017, NAT REV CLIN ONCOL, V14, P169, DOI 10.1038/nrclinonc.2016.162 | eng |
hcfmusp.relation.reference | Orting S., 2019, SURVEY CROWDSOURCING | eng |
hcfmusp.relation.reference | Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X | eng |
hcfmusp.relation.reference | Pantanowitz Liron, 2018, J Pathol Inform, V9, P40, DOI 10.4103/jpi.jpi_69_18 | eng |
hcfmusp.relation.reference | Pantanowitz Liron, 2017, J Pathol Inform, V8, P39, DOI 10.4103/jpi.jpi_46_17 | eng |
hcfmusp.relation.reference | Pantanowitz L, 2013, ARCH PATHOL LAB MED, V137, P1710, DOI 10.5858/arpa.2013-0093-CP | eng |
hcfmusp.relation.reference | Perkel JM, 2016, SCIENCE, V351, P1098 | eng |
hcfmusp.relation.reference | Piccart-Gebhart M, 2016, J CLIN ONCOL, V34, P1034, DOI 10.1200/JCO.2015.62.1797 | eng |
hcfmusp.relation.reference | Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450 | eng |
hcfmusp.relation.reference | Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086 | eng |
hcfmusp.relation.reference | Savas P, 2016, NAT REV CLIN ONCOL, V13, P228, DOI 10.1038/nrclinonc.2015.215 | eng |
hcfmusp.relation.reference | Schalper KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju435 | eng |
hcfmusp.relation.reference | Selleck MJ, 2017, BIOMARK INSIGHTS, V12, DOI 10.1177/1177271917715236 | eng |
hcfmusp.relation.reference | Singh U, 2018, BIOTECH HISTOCHEM, V93, P411, DOI 10.1080/10520295.2018.1445290 | eng |
hcfmusp.relation.reference | Stanton SE, 2016, JAMA ONCOL, V2, P1354, DOI 10.1001/jamaoncol.2016.1061 | eng |
hcfmusp.relation.reference | Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005 | eng |
hcfmusp.relation.reference | Stoler MH, 2000, MODERN PATHOL, V13, P275, DOI 10.1038/modpathol.3880048 | eng |
hcfmusp.relation.reference | Swiderska-Chadaj Z., 2018, CONVOLUTIONAL NEURAL | eng |
hcfmusp.relation.reference | Tellez D., 2019, QUANTIFYING EFFECTS | eng |
hcfmusp.relation.reference | Tellez D, 2018, IEEE T MED IMAGING, V37, P2126, DOI 10.1109/TMI.2018.2820199 | eng |
hcfmusp.relation.reference | U.S. Food and Drug Administration (FDA), 2018, CONS DES DEV AN VAL | eng |
hcfmusp.relation.reference | US Food and Drug Administration, YEAR 2 HIGH THROUGHP | eng |
hcfmusp.relation.reference | US Food and Drug Administration, DEV ADV AI MACH LEAR | eng |
hcfmusp.relation.reference | Van Eycke YR, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42964 | eng |
hcfmusp.relation.reference | Vayrynen JP, 2012, VIRCHOWS ARCH, V460, P455, DOI 10.1007/s00428-012-1232-0 | eng |
hcfmusp.relation.reference | Vis JY, 2016, INT J LAB HEMATOL, V38, P100, DOI 10.1111/ijlh.12503 | eng |
hcfmusp.relation.reference | von Minckwitz G, 2017, NEW ENGL J MED, V377, P122, DOI 10.1056/NEJMoa1703643 | eng |
hcfmusp.relation.reference | Wein L, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00156 | eng |
hcfmusp.relation.reference | Yi M, 2014, ANN ONCOL, V25, P1004, DOI 10.1093/annonc/mdu053 | eng |
hcfmusp.relation.reference | Yi X, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101552 | eng |
hcfmusp.relation.reference | Yoon HH, 2019, CLIN CANCER RES, V25, P125, DOI 10.1158/1078-0432.CCR-18-1984 | eng |
hcfmusp.relation.reference | Yousefi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11817-6 | eng |
hcfmusp.relation.reference | Yu XY, 2019, IEEE T NEUR NET LEAR, V30, P2805, DOI 10.1109/TNNLS.2018.2886017 | eng |
hcfmusp.relation.reference | Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330 | eng |
hcfmusp.relation.reference | Zarella MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174489 | eng |
hcfmusp.relation.reference | Zhang QS, 2018, FRONT INFORM TECH EL, V19, P27, DOI 10.1631/FITEE.1700808 | eng |
dc.description.index | PubMed | eng |
dc.identifier.eissn | 2374-4677 | - |
hcfmusp.citation.scopus | 84 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_AMGAD_Report_on_computational_assessment_of_Tumor_Infiltrating_Lymphocytes_2020.PDF | publishedVersion (English) | 3.04 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.